aska pharmaceutical raises ownership in ha tay pharmaceutical to nearly 33 per cent

ASKA Pharmaceutical raises ownership in Ha Tay Pharmaceutical to nearly 33 per cent

ASKA Pharmaceutical Co., Ltd. has increased its ownership of Ha Tay Pharmaceutical JSC (Hataphar) to 32.6 per cent through a private placement.
aska pharmaceutical to secure 33 per cent stake in hataphar

ASKA Pharmaceutical to secure 33 per cent stake in Hataphar

Upon the transaction's completion, the Japanese firm ASKA Pharmaceutical will possess 26.8 million shares in Ha Tay Pharmaceuticals (Hataphar), equating to nearly 33 per cent of the Vietnamese pharmaceutical company's equity.
japanese press on with expansions

Japanese press on with expansions

The efforts of Japanese investors to expand overseas business and diversify supply chains in the era of COVID-19 will be a boon to Vietnam.
japanese drug maker aska to acquire 249 per cent of ha tay pharmaceutical jsc

Japanese drug maker ASKA to acquire 24.9 per cent of Ha Tay Pharmaceutical JSC

ASKA Pharmaceutical Co., Ltd. (ASKA) announced that the company has completed negotiations to acquire 24.9 per cent of the shares of Vietnamese pharmaceutical company Ha Tay Pharmaceutical JSC (Hataphar).
japan singer aska reportedly arrested for drug possession

Japan singer ASKA reportedly arrested for drug possession

Japanese pop star ASKA was arrested on Saturday for possessing illegal stimulant drugs in his apartment in Tokyo, reports said.
pharmaceutical salaries up most in 2014

Pharmaceutical salaries up most in 2014

A recent survey by Towers Watson Vietnam revealed that salaries have increased 9.6 per cent this year on average, down from 11.7 per cent last year.
pharmaceutical violators under fire

Pharmaceutical violators under fire

Vietnam will continue clamping down firms that flout pharmaceutical quality standards.
incham launches pharmaceutical seminar

Incham launches pharmaceutical seminar

The Indian Chamber of Business in Vietnam (Incham) has organised a seminar on the pharmaceutical industry’s outlook this year with the participation of local state officials, hospital representatives, importers and their foreign partners at Sheraton Saigon Hotel.
innovating vietnams pharmaceutical sector

Innovating Vietnam's pharmaceutical sector

Traphaco JSC not only posted positive business results in 2021 but also registered an impressive momentum in the first quarter with an expected after-tax profit of $3.6 million, an increase of 50 per cent compared to the previous year. The pharmaceutical firm also makes shareholders and investors highly appreciate its progress in innovation and creativity, especially its corporate restructuring strategy.
new circular unsettles pharmaceutical giants

New circular unsettles pharmaceutical giants

Possible cuts in drug prices are worrying international pharmaceutical giants as Vietnam’s new tendering rules are set to take effect from October.
demand on the rise for pharmaceutical imports

Demand on the rise for pharmaceutical imports

The Vietnamese pharmaceutical market is turning into an Eldorado for foreign companies due to a significant increase in year-on-year domestic demand.
competition intensifies in pharmaceutical sector

Competition intensifies in pharmaceutical sector

After a tough 12 months, competition in Vietnam’s lucrative pharmaceutical industry is forecast to heat up in 2019, with domestic and international players in a race to reap the benefits from local policies and new free trade agreements. Bich Thuy reports.
pharmaceutical market abuzz with activity

Pharmaceutical market abuzz with activity

The local pharmaceutical market registers robust performance in the wake of growing M&A deals and outsiders’ new ventures into drug store chain launching.
more pharmaceutical firms want to remove fol

More pharmaceutical firms want to remove FOL

Southern bourse member Pymepharco (ticker PME) is the latest company to announce intentions to ramp up its foreign ownership limit to 100 per cent, following leading pharmaceuticals Duoc Hau Giang and Domesco.
pharmaceutical ma on the horizon

Pharmaceutical M&A on the horizon

The Vietnamese pharmaceutical market harbours immense potential, but domestic enterprises are exploiting only half of this at best. To not lose ground on their home turf, domestic players may increase their scale and capacity through merger and acquisition (M&A) in order to compete against foreign rivals.